Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ajanta Pharma Limited debt and liabilities for a breakdown of total debt and financial obligations.
Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
0.015x |
|
China Galaxy Securities Co Ltd
F:CGL
|
-0.495x |
|
Grandblue Environment Co Ltd
SHG:600323
|
0.085x |
|
Carnival Corporation & plc
F:POH1
|
0.116x |
|
Peyto Exploration&Development Corp
TO:PEY
|
0.081x |
|
Kenon Holdings
TA:KEN
|
0.034x |
|
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX
|
21.854x |
|
KENON HLDGS LTD
F:76N
|
0.032x |
Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Ajanta Pharma Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs37.90 Billion ≈ $409.91 Million |
Rs11.57 Billion ≈ $125.15 Million |
0.305x | +38.73% |
| 2024-03-31 | Rs35.67 Billion ≈ $385.80 Million |
Rs7.85 Billion ≈ $84.90 Million |
0.220x | -5.83% |
| 2023-03-31 | Rs33.88 Billion ≈ $366.40 Million |
Rs7.92 Billion ≈ $85.63 Million |
0.234x | +35.73% |
| 2022-03-31 | Rs32.64 Billion ≈ $353.03 Million |
Rs5.62 Billion ≈ $60.78 Million |
0.172x | -10.50% |
| 2021-03-31 | Rs29.96 Billion ≈ $323.97 Million |
Rs5.76 Billion ≈ $62.33 Million |
0.192x | +9.46% |
| 2020-03-31 | Rs25.99 Billion ≈ $281.06 Million |
Rs4.57 Billion ≈ $49.40 Million |
0.176x | +5.29% |
| 2019-03-31 | Rs22.45 Billion ≈ $242.81 Million |
Rs3.75 Billion ≈ $40.53 Million |
0.167x | +19.39% |
| 2018-03-31 | Rs20.41 Billion ≈ $220.77 Million |
Rs2.85 Billion ≈ $30.87 Million |
0.140x | -63.95% |
| 2017-03-31 | Rs15.68 Billion ≈ $169.54 Million |
Rs6.08 Billion ≈ $65.76 Million |
0.388x | +39.29% |
| 2016-03-31 | Rs11.72 Billion ≈ $126.75 Million |
Rs3.26 Billion ≈ $35.30 Million |
0.278x | -16.18% |
| 2015-03-31 | Rs8.41 Billion ≈ $90.96 Million |
Rs2.79 Billion ≈ $30.22 Million |
0.332x | -7.21% |
| 2014-03-31 | Rs5.93 Billion ≈ $64.16 Million |
Rs2.12 Billion ≈ $22.97 Million |
0.358x | -40.32% |
| 2013-03-31 | Rs3.93 Billion ≈ $42.51 Million |
Rs2.36 Billion ≈ $25.50 Million |
0.600x | +133.59% |
| 2012-03-31 | Rs2.98 Billion ≈ $32.23 Million |
Rs765.41 Million ≈ $8.28 Million |
0.257x | -41.57% |
| 2011-03-31 | Rs2.29 Billion ≈ $24.75 Million |
Rs1.01 Billion ≈ $10.88 Million |
0.440x | -14.54% |
| 2010-03-31 | Rs1.85 Billion ≈ $20.00 Million |
Rs951.16 Million ≈ $10.29 Million |
0.514x | +133.60% |
| 2009-03-31 | Rs1.57 Billion ≈ $16.99 Million |
Rs345.92 Million ≈ $3.74 Million |
0.220x | +55.96% |
| 2008-03-31 | Rs1.35 Billion ≈ $14.62 Million |
Rs190.81 Million ≈ $2.06 Million |
0.141x | -22.80% |
| 2007-03-31 | Rs1.16 Billion ≈ $12.50 Million |
Rs211.30 Million ≈ $2.29 Million |
0.183x | -21.67% |
| 2006-03-31 | Rs1.09 Billion ≈ $11.74 Million |
Rs253.45 Million ≈ $2.74 Million |
0.233x | +446.42% |
| 2005-03-31 | Rs978.24 Million ≈ $10.58 Million |
Rs-65.93 Million ≈ $-713.01K |
-0.067x | -- |
About Ajanta Pharma Limited
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more